M&A Announcement
Logotype for Poly Medicure Limited

Poly Medicure (531768) M&A Announcement summary

Event summary combining transcript, slides, and related documents.

Logotype for Poly Medicure Limited

M&A Announcement summary

25 Sep, 2025

Deal rationale and strategic fit

  • Acquisition provides entry into the fast-growing global orthopaedic trauma and extremity segment, a resilient $12 billion market expected to reach $16 billion, leveraging a differentiated, MDR-certified and patented product portfolio with strong positions in Italy, Mexico, and a growing U.S. presence.

  • The deal aligns with a strategy to expand into high-growth medical device segments, leveraging CTFE as a platform for global orthopedic expansion and accelerating growth in developed markets.

  • Integrated business model from R&D to distribution enables agile product development, rapid market entry, and strengthens innovation pipeline.

  • Direct sales presence in Italy, USA, and Mexico, with strong market positions in Italy and Mexico, supports global expansion ambitions.

  • Citieffe's strong R&D and patented portfolio align with the acquirer's mission to deliver innovative, patient-centric technologies.

Financial terms and conditions

  • 100% equity acquired for €18.8 million, with €4.2 million shareholder loan repayment, totaling €23 million payout at closing; €8.1 million net external debt assumed, valuing the company at €31 million enterprise value (EV/EBITDA 10.2x FY24).

  • CTFE/Citieffe reported €17.3 million revenue and €3.1 million EBITDA in 2024, with gross margins exceeding 90% and YoY growth of 15% and 14%, respectively.

  • Net block stands at €5 million, with total historical investment around $30 million.

  • Funded by internal accruals and cash balances.

Synergies and expected cost savings

  • Immediate synergy from adding plates and joint replacement to the product portfolio, enabling participation in more public tenders and entry into new markets.

  • Potential to double CTFE's business in five years by leveraging distribution networks and expanding into new geographies.

  • Outsourcing manufacturing to India expected to reduce costs, improve margins, and build a direct sales unit for CTFE products in India.

  • Synergies expected from integrating distribution networks and local manufacturing to enhance competitiveness and lower costs.

  • Expansion of distribution in markets where CTFE currently lacks presence.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more